Cryo-Cell International, Inc. (CCEL) To Go Ex-Dividend on November 15th

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) announced a — dividend on Wednesday, October 30th, Wall Street Journal reports. Shareholders of record on Friday, November 15th will be given a dividend of 0.25 per share on Friday, November 29th. The ex-dividend date is Friday, November 15th.

Cryo-Cell International Trading Down 1.1 %

Shares of NYSEAMERICAN:CCEL traded down $0.08 during midday trading on Friday, hitting $7.26. 47,205 shares of the company’s stock traded hands, compared to its average volume of 9,763. The firm has a market capitalization of $58.52 million, a price-to-earnings ratio of 13.54 and a beta of 0.45. Cryo-Cell International has a twelve month low of $3.67 and a twelve month high of $9.50.

Cryo-Cell International (NYSEAMERICAN:CCEL) last released its quarterly earnings results on Tuesday, October 15th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.11. Cryo-Cell International had a negative net margin of 28.03% and a negative return on equity of 42.06%. The firm had revenue of $8.07 million for the quarter.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.